Incretin mimetic
Incretin mimetic can refer to any drug that mimics the actions of one or more incretin hormones. They are used for type 2 diabetes.{{cite web |last1=Research |first1=Center for Drug Evaluation and |title=Incretin mimetic drugs for type 2 diabetes |url=https://www.fda.gov/drugs/information-drug-class/incretin-mimetic-drugs-type-2-diabetes |archive-url=https://web.archive.org/web/20190612183821/https://www.fda.gov/drugs/information-drug-class/incretin-mimetic-drugs-type-2-diabetes |url-status=dead |archive-date=June 12, 2019 |website=FDA |access-date=5 November 2023 |language=en |date=2 March 2022}}{{cite web |title=Incretin Based Treatments |url=https://dtc.ucsf.edu/types-of-diabetes/type2/treatment-of-type-2-diabetes/medications-and-therapies/type-2-non-insulin-therapies/incretin-based-treatments/ |website=Diabetes Education Online |access-date=5 November 2023}}
Specific incretin mimetics include:
References
{{reflist}}
{{set index}}